Capecitabine: guaranteed access in adjuvant treatment of breast cancer
- PMID: 36564161
- PMCID: PMC10800246
- DOI: 10.1136/ejhpharm-2022-003650
Capecitabine: guaranteed access in adjuvant treatment of breast cancer
Keywords: HEALTH SERVICES ADMINISTRATION; MEDICAL ONCOLOGY; PHARMACEUTICAL PREPARATIONS; PHARMACY SERVICE, HOSPITAL; Pharmacology.
Conflict of interest statement
Competing interests: None declared.
References
-
- AEMPS (Spanish Agency of Medicines and Health Products) . Summary of product characteristics (SmPC) Xelcip 500 mg tablets. CIMA (Medical Online Information Centre), Ministry of Health. Available: https://cima.aemps.es/cima/dochtml/ft/78583/FT_78583.html [Accessed 15 Nov 2022].
-
- Royal Decree 1015/2009, of 19 June, which regulates the availability of medicines in special situations. Official State Gazette (“BOE” in Spanish) No. 174 (20 July 2009). Available: https://www.boe.es/buscar/doc.php?id=BOE-A-2009-12002 [Accessed 15 Nov 2022].
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical